mobile header
telelphone

Overview

image

Ureter is a tube-like structure that carries urine from the kidneys to the bladder. Cells of the ureter or renal pelvis undergo changes (mutation), resulting in the transformation into cancer cells. These cells divide and grow uncontrollably.

Although uncommon, it mostly occurs in older adults and people who have previously been treated for bladder cancer. That said, the common types of ureteral cancer include urothelial carcinoma, adenocarcinoma, and squamous cell carcinoma.

Taking On Cancer, Together !​

Life does not stop when cancer strikes.​

We are with you in this fight to win over cancer. We are here to give you the strength to recover through a comprehensive cancer care program.

Request an Appointment
Life Does Not Support

Frequently Asked Questions (FAQs)

Ureteric cancer is a rare type of cancer that develops in the lining of the ureters, the tubes that carry urine from the kidneys to the bladder. At American Oncology Institute, specialists focus on early diagnosis and personalized treatment to manage this condition effectively.

Ureteric cancer is diagnosed through advanced imaging tests, urine cytology, cystoscopy, and biopsy. AOI uses state-of-the-art diagnostic facilities to ensure accurate detection and staging, helping doctors design the best possible treatment plan.

Yes, in many cases AOI specialists use minimally invasive procedures such as ureteroscopic surgery or laparoscopic nephroureterectomy, which help reduce recovery time and hospital stay while ensuring effective cancer management.

Symptoms of ureteric cancer may include blood in urine, back or flank pain, frequent urination, or urinary blockages. At AOI, experts recommend timely consultation if such symptoms persist, as early detection significantly improves treatment outcomes.

Treatment options for ureteric cancer at AOI include surgery, minimally invasive techniques, chemotherapy, immunotherapy, and targeted therapy depending on the stage and spread of cancer. A multidisciplinary team ensures every patient receives personalized care.

Yes, patients with ureteric cancer require regular follow-up to monitor recurrence or progression. AOI provides comprehensive post-treatment surveillance and support programs to ensure long-term patient well-being.

You can book an appointment with AOI’s cancer specialists for expert evaluation and treatment of ureteric cancer by visiting https://www.americanoncology.com/bookanappointment or by calling the helpline at 1800 208 2000.

American Oncology Institute stands out for its evidence-based treatment protocols, advanced technology, experienced oncologists, and a patient-first approach, making it a trusted center for ureteric cancer care.